Unichem Laboratories Limited

NSE: UNICHEMLAB · Unclassified

₹501.70+1.70%06 Nov 2026

Ask the data

Instant answers about Unichem Laboratories Limited — computed from its filings, no language model

Market cap₹3,532 cr

Current price₹501.70

High / Low₹651 / ₹284

P/E—

P/B1.27

Book value₹395.1

ROE0.0%

ROCE12.9%

Debt / equity0.17

Dividend yield—

EPS (TTM)₹0.00

Face value₹2

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 7 periods

	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	1,211	1,235	1,270	1,343	1,705	2,111	2,202
EBITDA	-51	91	73	-46	100	265	184
Operating margin	-4.2%	7.4%	5.7%	-3.4%	5.9%	12.5%	8.4%
Interest	8	5	6	17	23	21	32
Depreciation	82	84	91	113	113	125	125
Profit before tax	-49	52	23	-176	-62	155	292
Tax	12	17	-11	26	9	17	40
Net profit	0	0	0	-202	0	0	0
EPS ₹	-8.55	4.88	4.70	-28.72	-10.01	19.53	35.91
Operating cash flow	—	—	-260	-85	17	-7	4
Capex	—	—	127	44	23	137	123
Dividend paid	—	—	28	28	0	0	0
Total assets	—	—	—	3,193	3,169	3,569	3,737
Equity	—	—	—	2,435	2,362	2,451	2,717

Quarterly performance

last 30 quarters · ₹ crore

showing latest 8 of 30 periods

	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	298	296	297	320	317	318	326	274	298	291	311	370	310	329	302	402	423	416	434	432	446	462	533	587	527	579	521	575	633	640
Operating profit	-20	-27	-17	13	12	30	30	19	-2	7	-1	68	-1	-18	-43	16	28	9	38	25	44	58	86	84	22	66	45	48	70	74
Operating margin	-6.8%	-9.1%	-5.8%	4.2%	3.8%	9.4%	9.2%	6.9%	-0.6%	2.3%	-0.2%	18.5%	-0.3%	-5.6%	-14.1%	4.1%	6.6%	2.1%	8.8%	5.9%	9.7%	12.4%	16.0%	14.3%	4.3%	11.4%	8.6%	8.3%	11.1%	11.6%
Other income	26	28	25	12	17	10	16	8	16	3	15	14	8	9	16	5	9	6	11	6	4	9	14	9	7	21	12	23	16	15
Interest	1	2	2	2	1	1	1	2	1	2	1	2	3	5	4	6	6	7	6	5	4	5	7	5	7	8	7	9	7	8
Depreciation	18	21	19	23	21	21	21	22	22	22	23	23	25	28	31	30	29	29	28	27	28	29	31	30	32	31	31	31	30	30
Profit before tax	-13	-22	-14	-0	7	18	24	3	-9	-15	-11	58	-21	-47	-61	-47	2	-22	84	-126	15	33	62	58	-9	-11	293	19	49	27
Tax	-8	1	1	18	5	9	-0	3	2	-3	3	-14	3	23	3	-3	3	3	-0	3	6	2	4	5	1	1	29	8	8	5
Net profit	0	0	-15	0	2	0	0	0	0	0	0	0	-23	0	0	-44	-1	0	84	0	0	30	58	0	0	0	0	0	0	0
EPS ₹	-0.88	-3.15	-2.07	-2.44	0.35	1.24	3.35	-0.06	-1.63	-1.82	-2.01	10.15	-3.32	-10.04	-9.08	-6.28	-0.09	-3.48	11.93	-18.37	1.31	4.34	8.22	7.52	-1.49	-1.69	37.54	1.55	6.61	3.16
Revenue YoY	—	—	—	—	6.6%	7.4%	9.8%	-14.4%	-6.1%	-8.5%	-4.6%	35.0%	3.9%	13.1%	-2.8%	8.7%	36.7%	26.4%	43.6%	7.4%	5.5%	11.2%	22.7%	36.0%	18.0%	25.3%	-2.2%	-2.1%	20.1%	10.6%
Profit YoY	—	—	—	—	—	—	—	—	-100.0%	—	—	—	—	—	—	—	—	—	—	—	—	—	-31.1%	—	—	-100.0%	-100.0%	—	—	—

Earlier results (standalone, Sep '07 – Mar '19)

₹ crore · from BSE, before the NSE XBRL filings begin

Unichem Laboratories Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 11 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†
Revenue	657	691	765	803	1,005	1,044	1,091	1,222	1,414	1,106	969
Operating profit	154	179	161	127	183	181	100	142	162	-9	-61
Operating margin	23.5%	25.9%	21.0%	15.9%	18.2%	17.3%	9.2%	11.6%	11.5%	-0.8%	-6.3%
Other income	10	7	7	8	17	43	21	23	13	67	102
Interest	2	0	1	2	2	2	2	2	2	3	1
Depreciation	20	21	27	28	35	43	38	35	41	46	62
Profit before tax	144	164	140	105	162	228	82	128	132	9	-22
Tax	19	30	32	23	33	51	17	27	28	-2,547	-30
Net profit	125	134	108	82	130	177	64	101	104	2,557	9

Quarters

showing latest 8 of 47 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†
Revenue	150	139	138	182	177	152	146	169	175	173	174	188	202	197	178	189	199	223	193	265	264	233	244	266	270	265	244	291	278	266	256	309	306	306	302	342	368	360	344	314	428	159	205	201	246	245	277
Operating profit	30	23	20	42	45	37	31	45	46	46	42	48	50	39	24	27	30	37	33	48	53	40	42	51	50	48	32	44	33	8	15	43	34	34	31	44	40	44	34	-0	72	-55	-26	-39	2	-20	-5
Operating margin	20.2%	16.8%	14.2%	22.9%	25.5%	24.1%	21.1%	26.8%	26.5%	26.6%	23.9%	25.7%	24.5%	20.0%	13.3%	14.3%	15.3%	16.5%	17.1%	18.0%	20.0%	17.3%	17.2%	19.2%	18.6%	18.2%	13.0%	15.0%	12.0%	3.2%	5.8%	13.8%	11.3%	11.1%	10.4%	12.9%	10.8%	12.3%	9.8%	-0.1%	16.9%	-34.6%	-12.7%	-19.2%	0.7%	-8.0%	-1.7%
Other income	1	1	4	3	3	1	3	1	2	1	3	2	2	1	2	2	3	2	2	7	2	5	3	8	8	3	24	5	6	5	6	6	6	5	6	5	3	4	0	8	7	7	45	19	33	28	23
Interest	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	0	1	1	1	1	1	1	1	0	1	1	0	1	1	1	0	0	1	1	1	1	0	0	0	0
Depreciation	4	4	5	4	5	5	6	5	5	5	6	7	7	7	7	7	7	7	8	8	8	9	10	11	11	10	11	8	11	10	8	9	9	9	9	10	10	10	10	10	11	12	13	12	15	17	18
Profit before tax	27	20	19	40	43	33	28	41	42	42	39	43	45	34	19	22	26	32	26	46	46	36	35	47	46	90	44	40	28	2	12	40	31	30	27	39	32	38	23	-3	67	-61	6	-32	20	-9	-0
Tax	6	5	0	7	8	4	0	8	8	8	5	10	10	8	4	6	7	7	3	12	11	6	4	11	10	16	14	9	5	0	2	11	8	9	-1	13	11	12	-8	-5	21	-2,568	4	-11	4	-13	-10
Net profit	21	15	19	33	35	28	28	32	34	34	34	33	35	26	15	16	19	24	23	33	35	30	31	36	36	74	30	30	22	2	10	29	23	21	28	26	21	26	31	2	46	2,507	2	-21	15	4	10
EPS ₹	5.90	4.19	5.23	9.26	9.73	7.80	7.82	8.98	9.42	9.34	9.34	9.25	9.62	2.84	1.65	1.73	2.12	2.71	2.57	3.67	3.88	3.36	3.43	3.99	4.00	8.19	3.37	3.33	2.46	0.23	1.08	3.17	2.54	2.26	3.10	2.84	2.26	2.87	3.35	0.16	5.04	275.74	0.25	-2.94	2.16	0.61	1.41
Revenue YoY	—	—	—	—	17.7%	9.4%	5.8%	-6.7%	-1.2%	13.5%	18.8%	10.7%	15.7%	14.1%	2.4%	0.7%	-1.6%	13.0%	8.3%	40.3%	32.9%	4.5%	26.2%	0.3%	2.0%	13.9%	0.2%	9.6%	3.2%	0.4%	4.9%	6.2%	9.9%	15.2%	17.8%	10.6%	20.4%	17.5%	14.1%	-8.1%	16.3%	-55.8%	-40.4%	-35.9%	-42.6%	53.8%	35.1%
Profit YoY	—	—	—	—	64.9%	86.2%	49.6%	-3.0%	-3.1%	19.8%	20.2%	3.0%	2.1%	-24.0%	-56.2%	-53.2%	-44.8%	-4.4%	56.6%	112.2%	83.2%	24.0%	33.5%	8.9%	3.3%	144.4%	-1.8%	-16.3%	-38.4%	-97.2%	-67.8%	-4.7%	3.4%	897.1%	186.7%	-10.5%	-11.1%	27.1%	11.8%	-94.2%	123.3%	9501.8%	-92.8%	-1476.7%	-66.8%	-99.8%	341.8%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 27 periods

	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	—	—	-0.9%	-0.9%	-2.8%	-1.8%	-1.9%	1.6%	3.5%	3.6%	4.8%	3.7%	3.6%	3.6%	2.4%	0.0%	0.0%	0.0%	0.0%
ROCE	—	—	—	—	—	—	—	—	—	—	-0.4%	-2.0%	-5.8%	-4.9%	-4.0%	1.5%	-1.5%	-1.1%	0.9%	0.2%	6.5%	5.8%	4.4%	12.3%	10.2%	12.0%	12.9%
Net margin	-1.2%	-1.0%	-1.0%	0.2%	0.2%	0.0%	0.0%	0.0%	0.0%	-1.8%	-1.8%	-1.8%	-5.0%	-3.1%	-2.9%	2.3%	4.9%	4.9%	6.5%	4.7%	4.4%	4.2%	2.6%	0.0%	0.0%	0.0%	0.0%
EBITDA margin	-4.2%	-1.5%	3.0%	6.7%	7.4%	6.4%	4.6%	2.0%	5.7%	5.7%	3.7%	0.5%	-3.4%	-1.1%	0.7%	5.5%	5.9%	6.7%	9.3%	11.3%	13.3%	11.8%	11.6%	9.8%	8.2%	9.9%	10.0%
Debt / equity	—	—	—	—	—	—	—	—	—	—	0.12	0.12	0.12	0.12	0.11	0.11	0.09	0.09	0.11	0.11	0.18	0.18	0.19	0.19	0.17	0.17	0.17
Interest coverage	-5.24	-2.65	2.62	9.50	11.12	8.38	1.41	-4.03	4.78	2.40	-0.94	-4.33	-9.19	-6.66	-4.80	1.72	-1.72	-1.33	1.32	0.20	8.97	7.10	4.70	12.98	10.26	12.06	13.48
Asset turnover	—	—	—	—	—	—	—	—	—	—	0.42	0.41	0.42	0.46	0.50	0.55	0.54	0.55	0.54	0.57	0.57	0.59	0.63	0.62	0.59	0.62	0.61

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	14	14	14	14	14	14	14	14	14
Other equity / reserves	2,531	2,421	2,394	2,348	2,387	2,437	2,421	2,703	2,767
Total equity	2,545	2,435	2,408	2,362	2,401	2,451	2,435	2,717	2,781
Borrowings	293	297	276	219	268	430	474	469	475
Current liabilities	487	640	554	708	820	992	1,017	886	1,001
Non-current liabilities	132	118	108	99	91	127	105	134	125
Total assets	3,164	3,193	3,070	3,169	3,311	3,569	3,556	3,737	3,908
Property, plant & equipment	1,235	1,255	1,225	1,194	1,151	1,279	1,230	1,204	1,163
Capital work-in-progress	210	147	122	123	145	31	79	100	126
Investments	2	2	2	1	0	0	0	0	0
Inventories	591	625	638	705	837	989	978	975	1,083
Receivables	433	589	615	610	630	779	778	829	986
Cash & equivalents	337	184	63	151	188	90	178	289	157

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	-260	-85	17	-7	4
Cash from investing	100	203	50	-241	192
Cash from financing	191	-81	-106	184	2
Capex	127	44	23	137	123
Free cash flow	-387	-129	-6	-144	-119
Dividends paid	28	28	0	0	0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,163 cr30%

CWIP

₹126 cr3%

Investments

₹0 cr0%

Inventories

₹1,083 cr28%

Receivables

₹986 cr25%

Cash & equivalents

₹157 cr4%

Other assets

₹392 cr10%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Unichem Laboratories Limited	3,532	501.70	—	1.27	0.0%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-8.1%

6 months+27.9%

1 year+6.1%

3Y CAGR+7.1%

5Y CAGR+17.6%

10Y CAGR+6.3%

50-day avg₹528.39

200-day avg₹441.98

RSI (14)47

FAQs

What is the share price of Unichem Laboratories Limited?

Unichem Laboratories Limited (UNICHEMLAB) closed at ₹501.70 on NSE on 06 Nov 2026.

What is the market cap of Unichem Laboratories Limited?

₹3,532 crore at the latest close.

How fast is Unichem Laboratories Limited growing?

Unichem Laboratories Limited: revenue has compounded at 17.9% a year over three years. Latest-quarter revenue is up 10.6% year on year.

How profitable is Unichem Laboratories Limited?

On a trailing-twelve-month basis return on equity is 0.0%, return on capital employed 12.9%, operating margin 10.0%, net margin 0.0%.

How much debt does Unichem Laboratories Limited have?

Unichem Laboratories Limited is lightly geared: debt to equity is 0.17 with borrowings of ₹475 cr against cash of ₹157 cr (balance sheet of 2026-09-30). Operating profit covers interest 13.5 times.

Financials parsed from Unichem Laboratories Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '19, annual from FY20, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.